Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-07

FDA Approved: XANAX XR — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for XANAX XR (alprazolam) submitted by Viatris Specialty LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XANAX XR (alprazolam)

Snippet

SUPPL AP for XANAX XR (ALPRAZOLAM)